---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-115360"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2023-04-25T23:59:59+00:00"
generated_at: "2026-06-16T16:41:10.141105+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# GoodRx appoints Scott Wagner as Interim CEO; co-founders transition to Chairman and Chief Mission Officer

## Summary
- Scott Wagner, former CEO of GoDaddy, named Interim CEO effective April 25, 2023.
- Co-founders Trevor Bezdek becomes Chairman, Doug Hirsch becomes Chief Mission Officer.
- Wagner receives base salary, 100% target bonus, and option grant for 2.5M-3M shares vesting monthly.
- Bezdek and Hirsch each retain $500K base salary and 100% target bonus under 18-month employment agreements.
- Press release notes Q1 Monthly Active Consumers in range; full results on May 10 earnings call.

## SEC filing metadata
- accession: 0001193125-23-115360
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2023-04-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/d436463d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-115360
- JSON: https://secwatch.observer/filing/0001193125-23-115360.json
- Plain text: https://secwatch.observer/filing/0001193125-23-115360.txt

## Key facts
- Earnings Releases
  GoodRx Holdings, Inc. reported financial results for the first quarter ended March 31, 2023.
  - Period: the first quarter ended March 31, 2023
  - Result: reported results
  source text: On April 25, 2023, GoodRx Holdings, Inc. (the “Company”) issued a press release in connection with the executive leadership transition described in Item 5.02 of this Current Report on Form 8-K which addresses the Company’s financial performance for the first quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm
- Executive change
  Scott Wagner was appointed as Interim Chief Executive Officer at GoodRx Holdings, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: the Company’s Board of Directors (the “Board”) appointed Scott Wagner as Interim Chief Executive Officer of the Company (principal executive officer), effective April 25, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm
- Executive change
  Douglas Hirsch changed role as Chief Mission Officer at GoodRx Holdings, Inc..
  - Action: transitioned
  - Role: Chief Mission Officer
  source text: Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm
- Executive change
  Trevor Bezdek changed role as Chairman at GoodRx Holdings, Inc..
  - Action: transitioned
  - Role: Chairman
  source text: Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000119312523115360/0001193125-23-115360-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.